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Abstract
Background: Pulse pressure (PP), might be a stronger determinants of cardiovascular risk.
Objective: To investigate the effect of  interval training program on PP in subjects with hypertension.
Methods: Two hundred and forty five male patients with mild to moderate (Systolic Blood Pressure [SBP] between 140-
179 & Diastolic Blood Pressure [DBP] between 90-109 mmHg) essential hypertension were age-matched and grouped into
exercise and control groups. The exercise (work: rest ratio of  1:1) groups involved in an 8-weeks interval training programs
of between 45-60  minutes, at intensities of 60-79% of HR max (maximum heart rate), while the control group remained
sedentary during this period. SBP, DBP, VO
2
max and PP were assessed.
Results: Findings of the study revealed significant correlation between PP and blood pressure; correlation of PP with SBP
was much stronger (95% variance). Also, there was significant effect of  the exercise training program on SBP, DBP and PP.
Changes in VO
2
max also negatively correlated with changes in PP (r= -.285) at p<0.05.
Conclusion: Moderate intensity interval training programs is effective in the non-pharmacological management of
hypertension and may prevent cardiovascular event through the down regulation of PP in hypertension.
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Hypertension is a primary risk factor for coronary
heart disease, stroke, congestive heart failure, renal
failure and peripheral vascular disease1. The two
measures of blood pressure which represent the
peak and trough of  the sinusoidal wave form of
arterial pressure are systolic blood pressure (SBP)
and diastolic blood pressure (DBP) respectively.
Although, both measurements predict cardiovascular
risk, there is no a priori reason for supposing that
either provides the best possible measure of risk,
especially, since one (systolic) is a stronger predictor
than the other2. According to O’Rourka3, Safan and
Frohlich4, mean blood pressure or pulse pressure
(PP), might be stronger determinants of
cardiovascular risk but are not directly obtain from
current clinical measurements. However, PP can be
mathematically expressed as the difference between
SBP and DBP5.
Studies have reported a clear association
between PP and cardiovascular risk6, 7. These reports
are consistent with the pathophysiological processes
in the conduit vessels and heart of patients with
hypertension, especially in older subjects with systolic
hypertension and increased arterial stiffness.5 It has
been previously shown in a large French population
that in male subjects aged 40 to 69 years; increased
pulse pressure (PP) was a strong predictor of general
and cardiovascular mortality, especially coronary
mortality6. Data from previous studies on
hypertension7, suggest that PP itself  could be a major
predictor of  cardiac risk in different populations.
Studies8,9 have recommended various therapies
including exercise in the management of
hypertension. However, studies investigating the
relationship of  PP, blood pressure and cardiovascular
fitness in black African population seem scanty.
Therefore, the purpose of this study was
to investigate the effect of  interval training on blood
pressure and pulse pressure (PP) in the management
of  hypertension. For the purpose of  this study, three
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major null hypotheses were formulated and tested:
(1) there would be no significant correlation between
PP, SBP and DBP, (2) there would be no significant
effect of  interval exercise on PP. (3) there would be
no significant correlation between exercise changes




In the present study, age-matched randomized
double blind independent groups design was used
to determine the influence of  the interval exercise
on cardiovascular parameters. A week wash out
period was established and pretest was administered
to all subjects on the last day of the wash out period.
Following wash out and pretest, all subjects were
placed on methyldopa, the exercise group involved
in interval training programs for 8 weeks, while the
control group remained sedentary during the period.
At the end of the training and sedentary period,
another one week wash out period was established
and posttest was administered to all subjects on the
last day of the wash out period.
Population for the study was male essential
hypertensive subjects attending the hypertensive clinic
of Murtala Muhammed Specialist Hospital Kano
Nigeria. Subjects gave their informed consent in
accordance with the American College of Sports
Medicine (ACSM) guidelines.10 Ethical approvals were
granted by the Ethical Committee of Kano State
Hospitals Management Board and the faculty of
Health Sciences, College of Medicine, University of
Nigeria, Enugu Campus.
Only those who volunteered to participate
in the study were recruited. Subjects between the
age range of 50-70 years with chronic mild to
moderate and stable (>1 year duration) hypertension
(SBP between 140-179 & DBP between 90-109
mmHg) were selected. Subjects who had stopped
taking antihypertensive drugs or on a single
antihypertensive medication were recruited for the
study were also recruited.  All subjects were sedentary
and have no history of psychiatry or psychological
disorders or abnormalities.
 Underweight and obese (BMI < 18.5 & >
30 kg/m2 respectively), smokers, alcoholic, diabetic,
other cardiac, renal, respiratory disease patients were
excluded. Those involved in vigorous physical
activities and above averagely physically fit (VO
2
max
>27 & >33 ml/kg.min for over 60 & 50 years old
respectively) were also excluded.
A total of 323 chronic and stable, essential mild to
moderate male patients with hypertension satisfied
the necessary study criteria. Subjects were age-matched
and randomly grouped into exercise (162) and
control (161) groups.
All subjects on anti-hypertensive drugs were
asked to stop all forms of  medication and in
replacement, were given placebo tablets (consisted
of mainly lactose and inert substance) in a single blind
method11, 12. All subjects including those not on any
antihypertensive medications were placed on placebo
tablets for one week (7 days).
Subjects resting BP (SBP, DBP & HR) was
monitored from the right arm as described by Walker
et al13 using an automated digital electronic BP
monitor (Omron digital BP monitor, Model 11 EM
403c; Tokyo Japan). PP was obtained by subtracting
DBP from SBP. 14
 The Young Men Christian Association
(YMCA) sub-maximal cycle ergometry test protocol
was used to assess subject’s aerobic power as
described by ACSM 15 , Golding et al 16 .
The test procedure was conducted in the Department
of Physiotherapy of Murtala Mohammed Specialist
Hospital (MMSH), Kano between 8:00 am and 10:00
am.
Following stress test and prior to the exercise training,
all subjects in the exercise and control groups were
re-assessed by the physician and were prescribed with
aldomet (methyl-dopa) as necessary. During the
training and sedentary period (8 weeks) all subjects
in the interval, continuous and control groups were
placed on methyldopa according to their pre-
recruitment doses and responses at 250mg and
500mg daily. Methyldopa was preferred because it
does not alter normal hemodynamic responses to
exercise. 17. It is a well-tolerated and mostly
prescribed antihypertensive drug in Nigeria 18,
particularly Northern Nigeria where the study was
conducted and it is also useful in the treatment of
mild to moderately severe hypertension. 19 Subjects
maintained these prescriptions with regular medical
consultation and observation throughout the period
of  this study.
The exercise group (group 1)
After a 10-minutes warm up (pedaling at zero
resistance), subjects in the exercise group exercised
on a bicycle ergometer at a moderate intensity of
between 60-79% of their HR max (maximum heart
rate). 20, 21 that were estimated as stated below, from
220 minus the age of a subject as recommended by
ACSM. 22 The starting workload was 100 kgm (17
watts) which was increased at a pedal speed of
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50rpm to obtain 60% of their HR max was increased
in the first two weeks to and level up at 79% of
their HR max and this value was maintained
throughout the remaining part of the training period
at a work: rest duration of 1:1 of 6 minutes each. 24
During the 6-minutes rest interval period, subjects
pedal at zero intensity. The initial of  exercise session
was increased from 45 minutes in the first two weeks
of training to and leveled up at 60 minutes
throughout the remaining part of  the training.
Following the exercise, another 10- minutes cool
down was established by pedaling at zero resistance.
Exercise session of three times per week was
maintained throughout the 8 weeks period of
training.
The control group (group 3)
Subjects in the control group were instructed not to
undertake any organized/structured physical activity
apart from the activity of daily living during the 8
weeks period of  study.
Wash out period
At the end of the 8 weeks training and sedentary
period, all subjects remained sedentary (no exercise)
and were asked to stop methyldopa. Subjects were
instead prescribed with placebo tablets in a single
blinded method for one week in order to get rid
the effect of the methyldopa taken during the training
period.
 Post training physiological (SBP and DBP)
assessment and stress test were conducted as earlier
described in the pretest procedures using
standardized protocols, techniques and methods by
the same investigators.
All pre and post test measurements were recorded
on a data sheet. Two hundred and forty five subjects
(140 from exercise and 105 from control groups)
completed the eight weeks training program. Seventy
eight subjects (22 from exercise and 56 from control
groups) had dropped out because of non-
compliance, unfavorable responses to methyldopa
and exercise training or had incomplete data;
therefore, the data of 245 subjects were used in the
statistical analysis (figure 1).
Following data collection, the measured and
derived variables were statistically analyzed. The
descriptive statistics (Means & standard deviations)
of the subjects physical characteristics, estimated
VO
2
max and other cardiovascular parameters were
determined. Independent t test was conducted to
assess the treatment outcome. Pearson product
moment correlation test was also computed for the
variables (changes in PP, BP & changes in VO
2
max)
of interest. In the t-test and correlation tests, the
difference between subjects post-training and pre-
training measurements (changed score) were used
as dependent measures. All statistical analysis was
performed on a Toshiba compatible
microcomputer using the statistical package for the
social science (SPSS), windows Version 16.0 Chicago
IL, USA. The probability level for all the above tests
was set at 0.05 to indicate significance.
Results
The subject’s age ranged between 50 and 70years.
Mean age, height, weight and BMI ± SD: exercise
group (58.40±6.91years, 167.78±7.81cm,
70.18±11.37kg, 24.96±3.88 kg.m-2) and control
group (58.27 ±6.24years, 167.89±5.31cm,
68.47±17.07 kg, 24.16±4.91 kg.m-2). There was no
significant difference in age between groups (t=.156,
p=.876).
Subject’s pre versus (Vs), post treatment
mean BP ± SD mmHg, PP and VO
2
max ml.kg-
1.min-1 for the exercise (SBP166.05±14.10; DBP,
96.80 ±3.38; PP, 69.25±13.29 & VO
2
max
23.67±9.15 Vs SBP, 150.35±16.67; DBP, 94.08±5.31;
PP, 56.27±15.09 & VO
2
max 37.46±7.42) group and
control (SBP160.87±13.23; DBP, 97.17±1.43; PP,
63.70±12.21 & VO
2
max 21.23±5.76 Vs SBP, 163.47
±14.88; DBP, 96.10 ±2.67; PP, 67.37±14.12 &
VO
2
max 22.82±7.44) group (table 1).
Table 2 students’ test results indicated a
significant reduction in the exercise groups over
control in SBP (t=13.148, p=0.000), DBP (t= -6.560,
p=0.000), PP (t = -10.790, p=0.000) and VO
2
 max
(t= 11.959, p=0.000) at p<0.05.
Results showed significant positive
correlation between baseline PP and BP; SBP (r=
.971) and DBP (r= .214); the correlation of PP with
SBP was much stronger (95% variance). Result also
showed significant negative correlation between
changes in PP and changes in VO
2
 max (-.198) at
p< 0.05 (figure 2 & 3).
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Figure 1: Study design flow chat
Table 1: Groups pre and posttest mean(X) ± standard deviation (SD) (N = 245)
Variables       Exercise group Control group
X±SD  (n=140)    X±SD (n= 105)
Pretest                 Posttest Pretest                 Posttest
SBP(mmHg)                   166.05±14.10      150.35±16.67     160.87±23.91      163.47±14.88
DBP(mmHg)                  96.80±3.38         94.08±5.31         97.17±7.20          96.10±2.67
VO
2
max(ml/kg/min)      23.67±9.15         37.46±7.42         21.23±5.76          22.82±7.44
PP(mmHg)                     69.25±13.29       56.27±15.09 63.70±12.21 67.39±14.12
Table 2: Groups changed scores mean(X) ± standard deviation (SD) and t-test values
(N = 245)
Variables       Changed score values t-values p-values
          X±SD
                                      Exercise group    Control group
                                           n= 140               n= 105
SBP(mmHg)                     -15.70±13.16        2.61± 7.85       -13.148    0.000*
DBP(mmHg)                    -4.01±4.34           -1.07±1.76       -6.560      0.000*
VO
2
max(ml/kg/min)         13.79±9.99           1.59±  3.52     11.959      0.000*
PP(mmHg)                       -12.98±13.95         3.67±8.50    10.790      0.000*
* Significant, p< 0.05
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SBP r= 971* DBP r = 0.214* significant at 0.05*
Figure 2: Correlation between baseline (pretest) VO
2
max, SBP and DBP (n=140).
SBP r= -.971* DBP r = -0.304** PP r= -.289** significant at 0.05*  significant at 0.01**
Figure 3: Correlation between training changes in VO
2
max, SBP, DBP and PP (n=140).
Discussion
The purpose of the present study was to test three
null hypotheses as earlier stated. This study provide
evidence that (1) PP is significantly correlated with
both SBP and DBP (2) exercise significantly reduced




PP as defined in this study is derived by the difference
between two primary variables (SBP and DBP), and
hence a correlation between PP and the two primary
variables is statistically expected. It was also expected
that each primary variable will contribute about
equally to the variability of  PP. The situation is
analogues but not identical with the well recognized
problems in studying changes of a variable from
baseline, in which a derived variable is also calculated
by the difference. The present study confirmed that
the expected correlations were present, but the
correlation of PP with SBP was much stronger than
with DBP. Our finding is in agreement with the
report of Miller et al5; they reported that 90% of
the variance in PP was explained by SBP.
To eliminate selection bias by previous
study5, we selected subjects with mild (stage 1) to
moderate (stage 2) hypertension (SBP [140 -179],
DBP [90-109]), 1 yet, the correlation of PP with SBP
was much stronger, such that 93% of the variance
in PP was explained by SBP. Reason for this high
SBP variance in PP by our study could be the result
of wider range of SBP (179-140= 39mmHg)
compared to DBP (109-90= 19mmHg). Also, PP
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estimate from the difference of SBP and DBP in
the present study is not identical to pulse wave
amplitude. The clinical measurement of PP by
sphygmomanometer produces a value which is only
indirectly and approximately related to the real and
direct measurement of  PP. The administrative and
technical lag in the use of sphygmomanometer could
not be ruled out; the use of direct methods such as
aplanation tonometry seems more promising. 5
Another probable reason for high variance
of  SBP in PP might be age, many observational
studies evaluating the changing pattern of blood
pressure with the aging process have shown a
concomitant increase in systolic blood pressure (SBP),
diastolic blood pressure (DBP), and pulse pressure
(PP) until middle adult life. Beyond the approximate
age of 60 years, SBP continues to increase but DBP
reaches a plateau or gradually falls, and this leads to
an accelerated rise in PP. 23
Results of the present study revealed
significant reduction in interval group PP over
control group.  A similar result was reported by
Mughal et al 11; they investigated the effects of aerobic
exercise in patients with essential hypertension. 12-
weeks aerobic exercise intervention trial was
conducted, to examine the influence of brisk walking
on resting pulse pressure, mean arterial blood
pressure in patients with essential hypertension.
Twenty-seven men with stage 1 or 2 essential
hypertension (not on antihypertensive medication)
participated in the study. The aerobic exercise training
protocol consisted of 30 minutes of brisk walking
3 to 5 times per week, at 50% of VO
2
max on an
ergometer cycle. They reported statistically significant
decrease in pulse pressure from baseline value of -
3.7 mmHg, (p < 0.01). They concluded that aerobic
exercise caused small reductions in PP in men with
stage 1 or 2 essential hypertension.
The general consensus is that regular aerobic
exercise reduces blood pressure significantly in
patients with mild-to-moderate essential hypertension.
24 However, apart from blood pressure reduction;
our results also complement several others on the
therapeutic role of exercise in cardiovascular event
risk factor modification.
Clinical implication
SBP, DBP, and PP were all strongly associated with
increased risk factors for hypertension and
cardiovascular risk in hypertension. [6, 7, 25, 26]  There
seem to be a consensus that regular physical activity
can effectively and significantly control blood
pressure (SBP & DBP). [8, 9, 24] Though, PP is
mathematically derived from difference between
SBP and DBP, [5] however, it has been reported that
PP is a good index of arterial stiffness [27]. In spite
of this fact, regular physical activity has been proved
as an effective adjunct intervention with respect to







that could affect arterial stiffness, exercise
tolerance, functional capacity, physical work capacity,
quality of  life, survival and the mortality rate for
cardiovascular disease and all causes of diseases in
hypertension. [28, 29, 30]
Conclusion
Our study demonstrated a rationale bases for the
adjunct role of  long term moderate intensity interval
exercise training in the down regulation of blood
pressure and PP a major cardiovascular event risk
factor. Therefore, exercise specialists and other
therapists should feel confident in the use of this
form of  therapy in the non-pharmacological adjunct
management of hypertension.
Limitation of the study
The present study demonstrated a rationale bases
for the role of  interval exercise training in the down
regulation of  the blood pressure and PP. However,
the limitation of  the study includes failure to perform
the intension-to-treat analysis (ITTA) in the
randomized controlled trial. Though, it has been
reported that ITTA provides unbiased assessments
of treatment efficacy;[31] however, on-treatment
analysis (per protocol analysis) has the advantage that
it provides for a new treatment to show additional
efficacy and it most closely reflects the scientific
model underlined in the protocol.[32] These limitation
however, warrants attention in future studies.
Trial Registration
This work was registered by the Pan African Clinical
Trials Registry (PACTR), with Registration number:
PACTR201112000341237
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